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Summary
Tissue homeostasis is influenced by mechanical forces 
which regulate the normal function of connective tis-
sues. Mechanotransduction, the process that trans-
forms mechanical stimuli in chemical signals, involves 
mechanosensory units integrated in cell membrane. 
The mechanosensory units are able to activate gene 
expression for growth factors or cytochines as well as 
to induce a biological event which results in cell pro-
liferation and/or differentiation. In connective tissue 
the fibroblasts are the cells more represented and are 
considered as a model of mechanosensitive cells. They 
are ubiquitous but specific for each type of tissue. Their 
heterogeneity consists in different morphological fea-
tures and activity; the common function is the mech-
ano-sensitivity, the capacity to adhere to extracellular 
matrix (ECM) and to each other, the secretion of growth 
factors and ECM components. Extracorporeal shock 
waves (ESW) have been recently used to treat dam-
aged osteotendineous tissues. Studies in vitro and in 
vivo confirmed that ESW treatment enhances fibroblast 
proliferation and differentiation by activation of  gene 
expression for transforming growth factor β1 (TGF- β1) 
and Collagen Types I and III. In addition, an increase of 
nitric oxide (NO) release is even reported in early stage 
of the treatment and the subsequent activation of en-
dothelial nitric oxide synthase (eNOS) and of vascular 
endothelial growth factor (VEGF) are related to TGF- β1 
rise. The data have been related to the  increase of an-
giogenesis observed in ESW treated tendons, an ad-
ditional factor in accelerating the repairing process. A 
suitable treatment condition, characterized by a proper 
energy/shot number ratio, is the basis of treatment ef-
ficacy. Further ESWT applications are suggested in re-
generative medicine, in all cases where fibroblast ac-
tivity and the interaction with connective tissue can be 
positively influenced.
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Fibroblasts
Fibroblasts are spindle shaped cells found in the majority of 
tissues and organs of the body associated with extracellular 
matrix (ECM) molecules. They are identified as mesenchy-
mal connective tissue cells; the term “fibroblast” is a general 
one used for a variety of connective cell types. Fibroblasts 
are cells found throughout connective tissue such as ten-
don, ligament, skin but even myocardium, liver, lung, nerve, 
uterus and kidney. Since a specific marker for identification 
of fibroblasts is still lacking, it is evident that there many 
functional differences  between fibroblasts from  each of 
these sites which reflect different functions for each organ 
(1, 2). Interestingly, there are also variations among the fi-
broblasts within each site. There is a growing body of evi-
dence that within fibroblasts isolated from the skin or lung, 
some cells will have very different biochemical characteris-
tics. They may vary in their morphology, proliferation rate, 
surface markers, protein synthesis or response to a given 
stimulus. This difference among fibroblasts, or fibroblast 
subpopulations, is referred to as fibroblast heterogeneity. 
Heterogeneity has been defined in skin, kidney, lung, syno-
vial, gingival and corneal fibroblasts (3).
Fibroblasts are the major mechanoresponsive cell type and 
are highly heterogeneous 
Fibroblasts play a crucial role in remodeling of the extracel-
lular matrix by synthesizing and organizing connective tissue 
components.  They respond to various microenvironmental 
signal including soluble Cytokines and growth factors as well 
as cell matrix or cell-cell interactions that control the balance 
between synthesis and degradation of ECM (4). The ECM 
consists of a variety of substances, of which collagen fibrils 
and proteoglycans are truly ubiquitous. In addition to the pro-
teoglycans, the hydrophilic ECM includes a variety of other 
proteins such as noncollagen glycoproteins (5).
In response to inflammatory stimuli at sites of injury, the fi-
broblast undergoes a profound phenotypic transition, result-
ing in chemotactic migration from the wound margin into the 
zone of injury, accelerated degradation and provisional re-
placement of damaged extracellular matrix, and induction of 
additional autocrine and paracrine mediators including IL-1, 
IL-6, IL-8, TGF-β, prostaglandins, and nitric oxide (NO) (6) 
Since fibroblasts are heterogenous in proliferative capacity, 
in synthesis of collagen and other matrix proteins and in 
response to immune mediators and growth factors, selec-
tive increase in fibroblast subpopulations may explain the 
long-term effects of acute in vivo activation on fibroblast be-
haviour (3).
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How do fibroblasts sense mechanical stress  and how do 
they use this information to regulate ECM biosynthesis and 
turnover? Specific changes in ECM synthesis and degrada-
tion are an important part of cellular responses to mechani-
cal stress. 
Mechanical forces and tissue homeostasis
Mechanical forces play a regulatory role in tissue homeo-
stasis by influencing physical properties as well as cell mor-
pho- physiology (2).  Mechanical signals affect cell morphol-
ogy, cytoskeletal organization, cell survival, cell proliferation 
and  differentiation, gene expression as well as regulate the 
expression of different  proteins of ECM.  Those functions 
have been described as indirect or direct mediators and 
sensors of mechanical stress (7). Along with soluble media-
tors they are able to modify the metabolism and phenotype 
of the cell (8).
Mechanotransduction
Mechanotransduction is the process by which physi-
cal forces are converted into biochemical signals (9). A 
physical force can be applied in a variety of ways such as 
through substrate stretching or through movement of fluid 
or air. Mechanosensory units are integrated in membrane 
proteins such as ion channels, integrins, associated cyto-
plasmic complexes; they are switched by physical stimuli 
which result in biological events depending on the type of 
mechanical load, as well as on the tissue and  the context 
in which they are applied. The cells stimulated by physi-
cal forces interplay with their surrounding matrices: this is 
a crucial point in the following biological events. There is 
a transmission through protein-protein interactions that rely 
upon the dynamic assembly of physically coupled protein 
networks that link the ECM to cytoskeletal components, via 
transmembrane proteins (7). 
Physical forces even influence conformational changes of 
membrane proteins making unmasked cryptic binding or 
phosphorilation sites, or regions that display enzymatic ac-
tivity (10, 11).
The size of focal contact points and the following signaling 
activity is force dependent (12). The following intracellular 
signaling affects gene expression with alteration of binding 
properties and/or of enzymatic functions (13).
The integrins, the major transmembrane components, can 
trigger signals in response to pulling forces applied to their 
ECM ligands (13-15). They are mechanoreceptors and me-
diate mechanotransduction by transferring forces to specific 
adhesion proteins into focal adhesions which are sensitive 
to tension and activate intracellular signals (16).
Thus, integrins may function as mechanotransducers by 
aggregating in the focal adhesion sites to transduce the 
mechanical stress into chemical signals. Force probably 
accelerates integrin activation, both by extracellular and in-
tracellular rearrangements, and induces protein recruitment 
through protein stretching (17). 
Cell signaling pathway, of consequence, is switched on or 
off by multiple molecule changes, in a critical puzzle where 
physical characteristics of the external forces play a crucial 
role together with the type of tissue where they are applied.
Mechanoresponse can be ubiquitous but is specific 
There is a vast difference in cellular mechanobiological 
response depending on cell structure and cell mechano-
sensitivity. Connective tissue cells are able to distinguish 
between various modes of mechanical stress: compres-
sive [e.g. in cartilage (18)], tensile [e.g. in tendons (19)] and 
shear [e.g. in blood vessel wall (20)].  Integrins have been 
implicated as mechanoreceptors in a wide range of cells 
including myocytes , fibroblasts, endothelial cells , chondro-
cytes, and bone cells (21).
Growth factors release after mechanical stimulation
Cells dynamically adapt to force by modifying their behav-
iour and remodeling their microenvironment: the release of 
growth factors after mechanical stimulation can be consid-
ered as initial step in the regeneration of new supporting 
connective tissue (21). Studies have indicated that me-
chanical loading increases the expression of several growth 
factors and Cytokines, such as Insulin-like Growth Factor 1 
(IGF-1), Transforming Growth Factor-β1(TGF-β1), and In-
terleukin-6 (IL-6) (22). 
Cyclic stretching of fibroblasts, a well-known model of me-
chanical stress, was described to modulate secretion pat-
tern of growth factors by Skutek et al. (23): an increased re-
lease of Fibroblast Growth Factor-2 (FGF-2), TGF-β1, and 
Platelet Derived Growth Factor (PGDF) was recorded. In a 
previous report, Bishop et al. (24) showed that mechanical 
load enhanced the stimulatory effect of PDGF on procol-
lagen synthesis of pulmonary artery fibroblasts, confirming 
their earlier report (25) on the enhanced stimulatory effect 
- induced by mechanical load - of serum growth factors on 
cardiac fibroblast procollagen synthesis.
In vitro  as well as  in vivo experiments have shown an in-
creased expression of TGF-β in response to mechanic stim-
uli in a number of cell and tissue types. Moreover, mechani-
cally induced type I collagen expression in ligament fibro-
blasts, in cardiac fibroblast, and human intestinal smooth 
muscle cells is directly dependent on TGF-β  activity (22). 
Importantly, loading-induced type I and/or type III collagen 
expression appears to depend directly on TGF-β1 activity in 
human ligament and patellar tendon fibroblasts (26). Sev-
eral observations point to TGF-β1 as an essential mediator 
of mechanically induced collagen synthesis in a variety of 
cell types. In addition to TGF-β1, Connective Tissue Growth 
Factor (CTGF) could be implicated in a link between loading 
and collagen synthesis, possibly acting as a down-stream 
mediator of TGF-β1 action (27, 28). 
Fibroblasts firmly attach to their ECM substrate via matrix 
adhesion contacts on their cell surface  All matrix contacts 
contain integrin receptors as their major transmembrane 
proteins (29, 30). To establish new contacts with ECM, cells 
first have to activate integrins at their surface, mostly by sig-
naling from within the cell (31).
Tendons and tendon fibroblasts
Mammalian tendons are composed of cells and almost ex-
clusively of extracellular collagen fibrils embedded in a pro-
teoglycan/water extracellular matrix or ground substance 
(32, 33). Collagen fibrils, the main structural components of 
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(tendon) collagen fibers, are formed by aggregated microfi-
brils composed of molecules of collagen (34). Tendon cells 
are mostly (90-95%) represented by tenoblasts (fibroblasts) 
along with endothelial cells and some chondrocytes located 
in the areas of compression  (33). Chemical and mechanical 
stimuli may directly couple to functional responses such as 
changes in cell proliferation, growth factor release or gene 
expression. Growth factors may then act in an autocrine or 
paracrine fashion to ‘‘potentiate’’ the mechanical stimulus.
(35)
Forces may be transmitted to and from cells through the 
extracellular matrix with changes in mechanical forces and 
cell shape which act as a biological regulator (36). Interac-
tions between cells and extracellular matrix and exchanges 
between extracellular matrix and cells may be in a dynamic 
equilibrium: in vitro studies demonstrated that internal (cy-
toskeletal) and external (elastic) forces are related via in-
tegrins if the substrate of fibroblast cultures is stretched or 
compressed  (29, 37) .
Mechanoresponses of tendon fibroblasts 
The tendon fibroblast is considered a key player in tendon 
maintenance, adaptation to changes in homeostasis and 
remodeling in case of minor or more severe disturbances 
to tendon tissue (38).  Mechanoresponses of tendons, both 
anabolic and catabolic, are due to the activities of tendon 
cells in response to various mechanical loading conditions. 
As a dominant cell type in tendons, tendon fibroblast (or 
tenocyte) is the major mechanoresponsive cell in the tissue 
(28) and is certainly responsible for changes in tendons by 
altering ECM gene and protein expression  With the devel-
opment of many in vitro cell-loading systems, a spectrum of 
mechanoresponses of tenocytes and their molecular mech-
anisms have been extensively investigated in the past two 
decades (see 39 for review).
Wang et al. (39) showed that human tendon fibroblasts in-
crease in proliferation as well as gene expression and pro-
tein production of type I collagen in a stretching magnitude-
dependent manner. In addition, depending on stretching 
magnitude, cyclic stretching increased gene expression and 
production of type I collagen (28). 
Several cytokines and growth factors, e.g., insulin like 
growth factor I (IGF-I), transforming growth factor-β, and 
interleukin-6, have been implicated in mediating the effect 
of increased loading of the fibroblasts in the tendon to pro-
duce collagen (22, 23, 40). Moreover, TGF-β1 is known as 
a potent inducer of collagen expression, and its induction 
in response to loading may well be important for mediating 
mechanically induced type I and/or type III collagen expres-
sion in tendon and muscle tissue (26-28).
While collagen type I is the main component of col lagen 
fibers, collagen type III has been shown to be important in 
the regulation of initial fibril assembly and thus at the early 
stages of injury repair (41).
Tendon healing
Tendon healing is a complex process which involves many 
cellular, vascular, and extracellular matrix factors (42). Ac-
cording to Orhan et al. (43), the formation of adhesions, 
an increase in fibroblasts, organization of collagen, an in-
crease in capillaries and thickening of the epitenon may all 
be observed during the process of healing. Unfortunately, 
prolonged periods of immobilization of a limb or a joint may 
be complicated by atrophy of muscles and articular carti-
lage, osteoarthritis, skin necrosis, tendoncutaneous adhe-
sions and thrombophlebitis.  Any procedure which promotes 
tissue healing without triggering associated damage may 
decrease the incidence of complication after tendon injuries 
(see 44 for review). The response of fibroblasts to physical 
stimuli is, consequently, the rationale for taking into account 
physical modalities to treat damaged osteotendineous tis-
sues.
Effects of mechanotransduction from different biophysical 
stimulations, shock waves included   
Several studies have evaluated the effect of biophysical mo-
dalities on tendons and many physical modalities are used 
in the management of tendon disorders  (see 45 for review).
Pulsed magnetic fields with a frequency of 17 Hz resulted 
in improved collagen fiber alignment in a rat Achilles tendi-
nopathy model (46). In a rat Achilles tenotomy model, ap-
plication of pulsed magnetic field therapy to the repair site 
resulted in an increase in tensile strength of up to 69% (47).
The role of laser phototherapy in the management of ten-
don injuries has also been considered. In rabbits subjected 
to tenotomy and surgical repair of the Achilles tendon, la-
ser phototherapy resulted in increased collagen production 
(48). In an experimental rat model of Achilles tendon injury, 
low level laser therapy reduced histological abnormalities 
and oxidative stress leading to a reduction of fibrosis (49).
Radiofrequency coablation is a new application of bipo-
lar radiofrequency energy that creates a small, highly ener-
gized plasma at the tip of the active electrodes capable of 
breaking down molecular bonds of tissue. Radiofrequency 
coablation stimulates an angiogenic response in normal 
rabbit Achilles tendon(50). A prospective study performed 
on patients with recalcitrant plantar fasciosis that failed con-
servative care reported statistical improvement in outcome 
measures at 6 months and 1 year (51). The ability of bipolar 
radiofrequency to deliver energy to tendons, ligaments, fas-
ciae, and capsules transcutaneously (noninvasively) with-
out arthroscopy or surgical exposure offers several advan-
tages beyond the added safety (52).
Therapeutic ultrasounds have been taken into account as 
new tool to treat soft tissue ailments. There is strong sup-
porting evidence from animal studies about the positive ef-
fects of ultrasound on tendon curing. Tendon fibroblasts (or 
more generally ‘‘tendon cells’’ or ‘‘tenocytes’’) have been 
used to investigate the underlying mechanism of ultrasound 
in tendon healing: in vitro studies have demonstrated that 
ultrasound can stimulate cell migration, proliferation, and 
collagen synthesis of tendon cells. Moreover, ultrasounds 
enhance tenocyte proliferation which correlates with in-
creased gene and protein expressions of proliferating cell 
nuclear antigen (PCNA). It was shown that either continu-
ous or pulsed mode ultrasound treatment enhanced gene 
and protein expressions of types I and III collagen in an 
intensity-dependent manner. The molecular mechanism 
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underlying the stimulation on migration, proliferation, and 
collagen synthesis of tendon cells is possibly caused by the 
up-regulation of TGF-β (53). 
Low-intensity pulsed ultrasound (LIPUS), having re-
moved the thermal component found at higher intensities, 
may be taken into account to improve bone and soft tis-
sue healing.  Some preclinical studies that support the posi-
tive effect of LIPUS therapy on soft-tissue healing could be 
translated into human use; however, powered human stud-
ies together with the standardization of intensities and dos-
ages for each target tissue are needed to build a stronger 
clinical database for routine clinical use (54).
Extracorporeal shock waves. The application of shock 
wave therapy in certain musculoskeletal disorders has been 
around for approximately 20 years, and the success rate 
in non-union of long bone fracture, calcifying tendonitis of 
the shoulder, lateral epicondylitis of the elbow and proximal 
plantar fasciitis ranged from 65% to 91%. The complications 
are low and negligible (55, 56). 
Physical principles of shock waves
Shock waves used in extracorporeal shock wave treatment 
(ESWT) are high amplitude sound waves from a transient 
pressure disturbance that propagate in three-dimension 
space with a sudden rise from ambient pressure to its maxi-
mum pressure at the wave front. The waves are transmit-
ted to the patient through either water or a coupling gel. A 
shock wave is a sonic pulse that has certain physical char-
acteristics. There is an initial rise of a high peak pressure, 
sometimes more than 100 MPa (1000 bar) within less than 
10 ns (nanoseconds), followed with a low tensile amplitude 
(up to 10 MPa), a short life cycle of approximately 10 μs 
and a broad frequency spectrum in the range of 16 to 20 
MHz. Shock waves differ from ultrasound waves that are 
typically biphasic and have a peak pressure of 0.5 bar. In 
essence, the peak pressure of shock wave is approximately 
1000 times that of ultrasound wave (55).
Within the last 20 years the understanding of shock waves 
has continuously improved. The physical principles as well 
as the tissue effects have been widely investigated. Regard-
ing the action of shock waves on tissue, 4 phases have been 
postulated: 1) physical phase; extracellular cavitations, ion-
ized molecules and an increase of membrane permeability 
are direct effects of the shock waves; 2) subsequent physi-
cal-chemical phase; diffusible radicals and interactions with 
biomolecules; 3) chemical phase; may be accompanied by 
intracellular reactions and molecular changes; and 4) bio-
logical phase. Anyway, many of the shock wave-tissue in-
teractions are not yet completely understood and the exact 
mechanisms of shock wave therapy need to be fully identi-
fied (57).
Extracorporeal shockwave therapy
The initial therapeutic introduction of shock waves to the 
human body was to noninvasively treat kidney stones (litho-
tripsy), this technology has evolved to be considered the 
procedure of primary choice for urolithiasis (58). Since early 
nineties, many clinical studies on ESWT have been done 
to treat orthopaedic disorders, such as epicondylitis, painful 
heel syndrome, calcific tendonitis of the shoulder, chronic 
plantar fasciitis, nonunions, pseudarthrosis and femoral 
head necrosis in adults (59).  Despite the efficacy in clinical 
application, scientific evidence of shock wave therapeutic 
effects and biochemical mechanisms on tenocytes remain 
limited, and much remains to be learned about the etiology, 
pathophysiology and management of these tendinopathies 
(60).
Orhan et al. (61) created an experimental rat model to in-
vestigate the histopathological and biochemical effects of 
ESWT in the healing of Achilles tendon injury that may ac-
company fractures. Authors described that ESW treatment 
increased tendon healing rate, as indicated by increased 
collagen synthesis and the histological findings. The same 
Authors later adopted a rat model which differed slightly 
in the experimental design (partial tendon rupture instead 
of a full cut followed by suture). Histopathological analy-
ses showed an increase of the number of capillaries in the 
group subjected to ESWT and a significantly greater force 
was required to rupture the tendon in the study group (43).  
Johannes et al. (62) were the first who explored the in-
fluence of the energy density and the number of applied 
shockwaves on the viability of cell suspension of normal fi-
broblasts. The Authors reported that shock waves have a 
dose-dependent destructive effect on cells in suspension: 
the number of applied shots had a statistically significant 
influence on the decrease in growth potential compared to 
the control cells, a higher number of shock waves leading 
to a more severe depression in the growth potential of the 
shocked cells. The same Authors, by analyzing the rela-
tion between the logarithm of the number of shots and the 
growth potential of the viable shockwave treated cells, sup-
ported that a very low number of applied shockwaves had 
a stimulating influence on the growth potential of the cells 
subjected to ESW treatment.
This observation was comparable to previous report by 
Haupt and Chvapil (63) who showed a dose-dependent in-
fluence of shock waves on the healing of partial-thickness 
skin lesions in pigs. Low-dose shockwave treatment stimu-
lated the reepithelisation while intermediate-dose ESW 
treatment had no effect, and high-dose ESW treatment had 
an inhibiting effect.
Extracorporeal Shock Waves: mechanism of action on 
fibroblasts
In recent times, Berta et al. (64) treated normal fibroblasts in 
suspension with low- to medium- energy shock waves and 
evaluated fibroblast viability, the growth rate and pattern, 
and gene expression for TGF-β1 and col lagen types I and 
III - the main factors involved in the repair process. Low- to 
medium- energy shockwave treatment induced fewer imme-
diate cytodestruc tive effects and there was a better subse-
quent stimulation of cell proliferation, in accordance with the 
work of Wang et al. (65, 66) and Martini et al. (67).
Fibroblast viability was influenced by the number of shots 
much more than by energy level and there was evidence of 
a suitable energy/shot number ratio to have a minor cytoci-
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dal effect. Shock waves had a dose-depen dent destructive 
effect on cells in suspension, as well as they had a dose-
depen dent stimulatory effect on cell proliferation. In addi-
tion, a significant increase in proliferation rate was observed 
with respect to the unshocked cells. A critical increase in cell 
growth was observed from the sixth to the twelfth day of the 
proliferation curve.
Bearing in mind that the goal of ESW treatment of tendon le-
sions is to promote and improve the repair process,  Authors 
concluded that treat ment at the 0.22 mJ/mm2 energy level 
with 1,000 impulses appears to be the condition in which 
fibroblast viability fits growth dynamics.
The pattern of expression of TGF-β1 mRNA showed higher 
values in treated fibroblasts than in untreated fibroblasts for 
day 6 (p = 0.02) and day 9 (p = 0.02), respectively. Elevated 
expression of mRNA was observed for collagen types I and 
III, although with different timing: on the sixth day for colla-
gen type I and on the ninth day for collagen type III. In both 
cases, ESW treatment enhanced expression of the genes 
encoding collagen types I and III.
The timing of increase of mRNA expression for TGF-β1 and 
for col lagen types I and III is in accordance with the role of 
collagen types I and III in repairing process and confirms 
that TGF-β1 is involved in differentiation of fibroblasts, ac-
cording to previous reports (60, 68). 
Hausdorf et al. (69) evaluated the capability of shockwave 
therapy to evoke the release of bone growth factors (namely 
TGF-β1 and FGF-2)  from target tissue cells like fibroblasts 
and osteoblasts which are essential parts of the tissue of a 
nonunion treatment.  While Transforming Growth Factor-β1 
(TGF-β1) is responsible for multiple reactions in tissue 
growth and is not only produced in osteoblasts and fibro-
blasts (70), Fibroblast Growth Factor-2 (FGF-2) represents 
a more selective bone growth factor. Fibroblast and osteo-
blast production of TGF-β1and of FGF-2,  predominant ele-
ments in the osteoneogenesis cascade, was shown to be 
increased after ESW treatment. 
Chen et al (68) evaluated the effect of various ESW treat-
ment schedules on the healing of collagenase-induced 
Achilles tendinitis, and investigated biochemical and biome-
chanical properties of healing tendons. 
Rats with the collagenease-induced Achilles tendinitis were 
given a single ESW treatment at 0.16 mJ/mm2 energy flux 
density, with different number of shots. Low number (200) of 
impulses restored biomechanical and biochemical charac-
teristics of healing tendons 12 weeks after treatment, while 
500 and 1000 shots elicited inhibitory effects on tendinitis 
repair. Within 1 week and 6 weeks after ESW, a large num-
ber of tenocytes displayed intensive proliferating cell nucle-
ar antigen (PCNA) expression after ESW treatment, sug-
gesting that physical ESW could increase the mitogenic re-
sponses of tendons. Moreover, the proliferation of tenocytes 
adjunct to hypertrophied cell aggregate and newly formed 
tendon tissue coincided with intensive TGF-β1 expression 
observed in the early stage of tendon repair, while elevated 
IGF-I expression persisted throughout the healing period. 
The stimulatory effect on tendon cell proliferation through 
PCNA-related pathway was confirmed by Tsai et al. (71) in 
ultrasound treated rat tendon fibroblasts.
Shockwave induced Nitric Oxide production
Van Griensven et al. (72) observed that cyclic mechanical 
strain induced NO production in human patellar tendon fi-
broblasts. The levels of released NO by the tendon fibro-
blasts varied with the duration of strain application: short 
strain duration induced an immediate, transient occurrence 
of high levels of NO. Authors hypothesized that NO pro-
duced by tendon fibroblasts, as a response to alteration of 
their mechanical microenvironment, could modulate fibro-
blast function.
The association between increase in NO production and 
collagen synthesis still has to be fully explained. One ex-
planation may be related to TGF-β1. Vodovotz et al. (73) 
showed that NO can lead to the activation of latent TGF-β1. 
Besides TGF-β1, other cytokines such as basic Fibroblast 
Growth Factor (b-FGF), Nuclear Transcription Factor-kap-
paB (NF-kB) and Insulin-like Growth Factor (IGF) can be 
induced by NO in wound healing and these cytokines also 
play an important role in collagen synthesis (74-76).
Chao et al (60) observed that  shockwave treatment on 
tenocyes harvested from rat Achilles tendons elicited up-
regulation of proliferating cell nuclear antigen (PCNA) and 
collagen types I and III as well as TGF-β gene expression; 
these were followed by the increases in NO production, 
TGF-β1 release and collagen synthesis.
A growing number of studies demonstrated that shockwave 
treatment rapidly induces elevation of systemic nitric oxide 
(NO) level and subsequent increases in systemic osteo-
genic factors in non-union of long bone (77, 78). Others 
reported NO as the mediator in callus formation in fracture 
healing after mechanical stimulation (79).
A rapid and non-enzymatic formation of NO was observed 
by Gotte et al. (80) by treating with SW a solution containing 
1mM hydrogen peroxide and 10mM l-arginine and ESW-
elicited production of nitrites increased in dependence on 
the number of shots.
Nitric oxide and VEGF had been demonstrated as important 
mediators of angiogenesis (81, 82). Wang et al. (83) showed 
that shock wave therapy induces the ingrowth of neo-ves-
sels and tissue proliferation associated with the early re-
lease of angiogenesis- related factors including endothelial 
nitric oxide synthase (eNOS) and VEGF at the tendon–bone 
junction in rabbits. Therefore, the mechanism of shock wave 
therapy appears to involve the early release of angiogenic 
growth factors in one week, and induces cell proliferations 
and formation of neovessels in approximately four weeks 
at the tendon– bone junction. The neovascularization may 
lead to the improvement of blood supply and play a role in 
tissue regeneration at the tendon–bone junction.
It appears that the mechanism of shock wave therapy in-
volves the early release of angiogenic growth factors (eNOS 
and VEGF) and subsequent induction of neovascularization 
and tissue proliferation. The neovascularization may play a 
role in pain relief of tendinitis and the repair of chronically 
inflamed tendon tissues.
In this context, it is of interest the recent report by Yin et al. 
(84) who showed that extracorporeal shockwave enhances 
angiogenesis and osteogenesis gene expression in bone 
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marrow stromal cells from hips with osteonecrosis through 
the NO-mediated pathway. The role of NO as a non neg-
ligible mediator factor of repairing process has been evi-
denced. Moreover, as suggested by Mariotto et al. (85), the 
clinically observed anti-inflammatory action of shock waves 
may, at least in part, be mediated by a  shockwave-induced 
increase in NO production.
Shock waves, fibroblasts and wound healing
Wound healing proceeds through a complex series of 
events involving inflammatory, proliferative, and remodeling 
phases (86). The proliferative phase of wound healing con-
sists of rapid fibroblast growth and increased synthesis of 
collagen/NCP in response to chemotactic factors released 
during the inflammatory phase. Wound healing is marked 
by angiogenesis through which ingrowth of capillaries ac-
companies fibroblast and osteoblast (in the case of bone) 
proliferation to form granulation tissue. Finally, fibroblasts 
maintain collagen production, which accumulates during the 
remodeling phase (87).
In early 2000, as it was definetly  demonstrated that ESW 
treatment is effective in promoting the healing of fractures 
and injuries by stimulated expression of  growth factors and 
eNOS, some authors started to investigate whether this ap-
proach was feasible and useful from the perspective of plas-
tic surgery by dealing with the critical problem of ischemic 
tissues in reconstructive procedures (88, 89). 
Prior animal studies (63) indicated positive influence of 
shock waves on the reepithelalization of partial-thickness 
wounds in Yorkshire piglets.  Experimental results obtained 
in a dorsal skin flap rodent model indicated that ESW treat-
ment substantially increased  PCNA expression, especially 
that of fibroblasts in the basal layers of epidermis and sub-
cutaneous layers, reduced leukocyte infiltration, and elicited 
suppression of tumor necrosis factor alpha expression in 
flap tissue ischemic zone.  Immunohistochemical study 
evidenced angiogenesis as demonstrated by VEGF expres-
sions in the flap tissue ischemic zone. VEGF expression 
was even significantly increased, particularly in fibroblasts 
and endothelial cells (90, 91). Moreover, a significant bac-
tericidal effect of high energy shock waves -  in an energy-
dependent manner  - was observed in vivo by Gerdesmeyer 
et al. (92). Later, Kuo et al. (93) observed, in a skin-flap 
rodent model, that ESW application reduced tissue necrosis 
by increasing cellular proliferation, especially by recruiting 
fibroblast proliferation and actively producing procollagen. 
Flap-tissue ischemic injury was thereby attenuated and tis-
sue repair increased.  Further, the eNOS expression level 
in the ischemic zone of the flap tissue after application of 
ESWs was significantly greater. Thus, flap survival might be 
promoted by ESW treatment, at least in part, by attenuat-
ing oxygen radicals and recruiting eNOS expression in the 
ischemic zone of the flap tissue.  Moreover, adopting a rat 
model of STZ-induced diabetes,  Authors showed that ESW 
treatment enhanced wound healing through an increase in 
the PCNA expression levels, especially in the fibroblasts 
in the basal epidermal and subcutaneous layers (94). The 
expression levels of VEGF were evidently up-regulated, 
particularly in the fibroblasts and endothelial cells. Further-
more, the rats in the ESW groups exhibited a marked de-
crease in the leukocyte-mediated inflammatory response. 
Most recent studies, which addressed the clinical utility of 
this approach, confirmed positive responses of shockwave 
therapy for soft tissue indications in addition to enhanced 
neovascularization (95-97) and potential tissue regenera-
tion (98-100). This modality has been investigated in a vari-
ety of traditionally problematic soft tissue wounds including 
diabetic foot ulcers (101),  burns (102), and chronic decubi-
tus ulcers (103).
Animal work and preliminary human experimental data 
point to a complex, multifactorial mechanism of therapeutic 
shock waves; however, that shockwave therapy has an ef-
fect on biological tissue based on the current level of scien-
tific knowledge is incontrovertible.
The report released at the beginning of 2012 by Ottomann 
et al. (104) describes a clinically important effect of low 
energy shock waves in superficial second-degree burns: 
although the study is limited by modest sample size and 
lacks of long-term follow-up, the difference in time to com-
plete burn site healing was highly significant in favour of the 
shock wave treated group.
The efficacy of ESWT for chronic ulcers warrants confirma-
tion in further prospective randomized clinical trials.  Shock-
wave therapy may prove to be a feasible, noninvasive, safe, 
and cost-effective method to enhance the healing of both 
acute and chronic soft tissue wounds.
Concluding remarks and perspectives
Fibroblasts are considered the primary source of most ex-
tracellular  matrix (ECM) components: thus they result the 
key mediator between external and internal environment. 
As mechanoresponsive cells, they convert  mechanical sig-
nals into biological events such as expression of numerous 
genes, including those responsible for ECM. In this context 
it is of interest their non negligible role both in tissue homeo-
stasis and in repairing processes. 
Fibroblast cells are ubiquitous but they are specific for each 
type of tissue. This difference among fibroblasts is referred 
to as fibroblast heterogeneity and fibroblast subpopulations 
have been identified in various tissue where they can have 
different morphological features and activity. Nevertheless, 
they share common functions: mechanosensitivity, adhe-
sion capacity to ECM and to each other, secretion of col-
lagen and growth factors..
Fibroblasts grown in tissue culture have been shown to re-
act within minutes to a variety of mechanical stimuli (stretch, 
pressure, traction, shear forces) with cellular responses 
ranging from changes in intracellular ATP release to signal-
ing pathway activation. 
In this review we considered the effect of ESWT on fibro-
blasts as a model of therapeutic application of the me-
chanical source. Studies on fibroblasts in vitro and in vivo 
confirm that shockwaves stimulate fibroblast activity; it is 
now scientifically established that ESW activate fibroblasts 
proliferation rate, collagen synthesis and gene expression 
for Growth factors and/or Cytochines. Moreover, a relation-
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ship was found between NO production and TGF-β1 gene 
expression in the early stage of ESW treatment as well as 
an increased gene expression both for eNOS and VEGT 
has been demonstrated in ESW treated tendons. The data 
can be related to the increased blood flow observed in ESW 
treated tissues. Both effects of ESW treatment on fibroblast 
activity and increase of blood flow cooperate to accelerate 
repairing process.
Shockwaves have been used successfully in the treatment 
of several chronic tendon ailments; recently they have been 
applied in acute phlogosis of soft tissues as bursitis or trau-
matic tendonpathies. Their efficacy has been demonstrated 
even in accelerating the wound repairing. Of consequence, 
ESWT can be applied  in regenerative medicine, in all cases 
where fibroblast activity and the interaction with connective 
tissue can be positively influenced. 
This  novel approach with an existing technology shows a 
comparable, if not greater, efficacy relative to current thera-
peutic approaches: noninvasiveness, highly favorable side-
effect profile, no known drug interactions, time-efficient sim-
plicity of use, and cost effectiveness.
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